Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Disopyramide phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Disopyramide 250mg modified-release tablets
0203020G0AAACAC
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | 1,206 |
|
Disopyramide 150mg modified-release tablets
0203020G0AAAEAE
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
|
Disopyramide 250mg modified-release capsules
0203020G0AAABAB
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
|
Disopyramide 50mg/5ml solution for injection ampoules
0203020G0AAAFAF
|
Disopyramide phosphate | Disopyramide phosphate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.